Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Thyroid Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Gastric Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Colon Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Malignant Adenoma

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

RESILIENT: A Randomized, Open Label Phase 3 Study of Irinotecan Liposome Injection (ONIVYDE®) versus Topotecan in Patients with Small Cell Lung Cancer Who Have Progressed on or after Platinum-based First-Line Therapy (MM-398-01-03-04)

  • Details

ClinicalTrials.gov ID: NCT03088813
Diagnosis Type: NA
USOR Number: 17099

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)

  • Details

ClinicalTrials.gov ID: NCT04083976
Diagnosis Type: NA
USOR Number: 19092

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

(MO40597) A MULTICENTRIC, OPEN-LABEL, SINGLE ARM STUDY OF OBINUTUZUMAB SHORT DURATION INFUSION (SDI) IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA (PHASE IV STUDY)

  • Details

ClinicalTrials.gov ID: NCT03817853
Diagnosis Type: NA
USOR Number: 18265

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

QBGJ398-302: Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Alterations (PROOF302)

  • Details

ClinicalTrials.gov ID: NCT04197986
Diagnosis Type: NA
USOR Number: 19094

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 510 Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and AMG 510 Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreak 100) (20170543)

  • Details

ClinicalTrials.gov ID: NCT03600883
Diagnosis Type: NA
USOR Number: 19024

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Pancreatic Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 510 Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and AMG 510 Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreak 100) (20170543)

  • Details

ClinicalTrials.gov ID: NCT03600883
Diagnosis Type: NA
USOR Number: 19024

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 510 Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and AMG 510 Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreak 100) (20170543)

  • Details

ClinicalTrials.gov ID: NCT03600883
Diagnosis Type: NA
USOR Number: 19024

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 510 Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and AMG 510 Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreak 100) (20170543)

  • Details

ClinicalTrials.gov ID: NCT03600883
Diagnosis Type: NA
USOR Number: 19024

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Colon Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 510 Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and AMG 510 Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreak 100) (20170543)

  • Details

ClinicalTrials.gov ID: NCT03600883
Diagnosis Type: NA
USOR Number: 19024

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 510 Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and AMG 510 Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreak 100) (20170543)

  • Details

ClinicalTrials.gov ID: NCT03600883
Diagnosis Type: NA
USOR Number: 19024

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

Brigatinib-3001- A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG®)Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)

  • Details

ClinicalTrials.gov ID: NCT03596866
Diagnosis Type: NA
USOR Number: 18129

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment with Ibrutinib (BGB-3111-215)

  • Details

ClinicalTrials.gov ID: NCT03206918
Diagnosis Type: NA
USOR Number: 18263

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Leukemia

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment with Ibrutinib (BGB-3111-215)

  • Details

ClinicalTrials.gov ID: NCT03206918
Diagnosis Type: NA
USOR Number: 18263

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
540.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Pages